Avenue Therapeutics Inc (ATXI)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

2 GANSEVOORT STREET NEW YORK, NY 10014

Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.

Data as of 2021-10-09 10:29:36 -0400
Market Cap22.335 Million Shares Outstanding16.793 Million Avg 30-day Volume52.127 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-6.61 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.50874 52-week High/Low7.69 / 1.27 Next Earnings Date2021-11-03 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ATXI instead.

View recent insider trading info

Funds Holding ATXI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ATXI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

7.2 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VAZZANO JOSEPH WALTER CHIEF FINANCIAL OFFICER

  • Officer
65,252 2021-09-15 1

HERSKOWITZ NEIL

  • Director
134,724 2021-05-06 1

KRANZLER JAY D

  • Director
84,663 2020-06-16 0

LU LUCY PRESIDENT, CEO

  • Officer
  • Director
0 2020-02-12 0

INGRAM ELIZABETH GARRETT

  • Director
16,000 2019-09-12 0

MOORE THOMAS GREGORY

  • Director
0 2019-04-30 0

INVAGEN PHARMACEUTICALS, INC.

10,006,762 2019-02-08 0

SAXENA NISHANT

0 2019-02-08 0

GOGTAY JAIDEEP ASHOK

0 2019-02-08 0

PALEY JEFFREY

  • Director
79,663 2018-12-03 0

ROSENWALD LINDSAY A MD

  • Director
84,663 2018-08-07 0

WEISS MICHAEL S

  • Director
24,663 2018-08-07 0

SAMAD AKHTAR

  • Director
64,663 2018-08-07 0

REINES SCOTT INTERIM CHIEF MEDICAL OFFICER

  • Officer
45,000 2018-08-07 0

FORTRESS BIOTECH, INC.

  • 10% Owner
3,566,259 2017-03-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VAZZANO JOSEPH WALTER - Officer CHIEF FINANCIAL OFFICER

2021-09-15 16:03:13 -0400 2021-09-15 S 7,160 $1.62 d 65,252 direct -0.6024 -4.8193 0.0 1 -7.8313 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AVENUE THERAPEUTICS INC ATXI 2021-10-15 22:15:04 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 21:45:03 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 21:15:03 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 20:45:03 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 20:15:03 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 19:45:03 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 19:15:04 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 18:45:03 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 18:15:03 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 17:45:03 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 17:15:03 UTC -1.1274 1.1974 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 16:45:03 UTC -1.1047 1.1747 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 16:15:03 UTC -1.1047 1.1747 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 15:45:03 UTC -1.1047 1.1747 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 15:15:03 UTC -1.1047 1.1747 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 14:45:02 UTC -1.0085 1.0785 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 14:15:03 UTC -1.0085 1.0785 200000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 13:45:03 UTC -1.0085 1.0785 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 13:15:03 UTC -1.0085 1.0785 250000
AVENUE THERAPEUTICS INC ATXI 2021-10-15 12:45:03 UTC -1.0085 1.0785 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ATXI -1200.0 shares, $-3012.0 2021-06-30 N-PORT

Elevate your investments